期刊
NUCLEAR MEDICINE AND BIOLOGY
卷 38, 期 2, 页码 273-277出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2010.08.003
关键词
CUMI-101; MMP; 5-HT1A; Cortex; Hippocampus; WAY100635
Introduction: Development of agonist positron emission tomography (PET) radioligands for the 5-HT neurotransmitter system is an important target to enable the understanding of human 5-HT function in vivo. [C-11]CUMI-101, proposed as the first 5-HT1A receptor agonist PET ligand, has been reported to behave as a potent 5-HT1A agonist in a cellular system stably expressing human recombinant 5-HT1A receptors. In this study, we investigate the agonist properties of CUMI-101 in rat brain tissue. Methods: [S-35]-GTP gamma S binding studies were used to determine receptor function in HEK (human embryonic kidney) 293 cells transfected with human recombinant 5-HT1A receptors and in rat cortex and rat hippocampal tissue, following administration of CUMI-101 and standard 5-HT1A antagonists (5-HT, 5-CT and 8-OH-DPAT). Results: CUMI-101 behaved as an agonist at human recombinant 5-HT1A receptors (pEC(50) 9.2). However, CUMI-101 did not show agonist activity in either rat cortex or hippocampus at concentrations up to 10 mu M. In these tissues, CUMI-behaved as an antagonist with pK(B)s of 9.2 and 9.3, respectively. Conclusions: Our studies demonstrate that as opposed to its behavior in human recombinant system, in rat brain tissue CUMI-101 behaves as a potent 5-HT1A receptor antagonist. (C) 2011 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据